Spring Bank to Present Data on its Novel Chimeric Antisense Oligonucleotide Compounds for Hepatitis B at HepDART 2019

NEXT STORY
BeyondSpring’s Abstracts on Clinical Evidence for Bone Marrow Stem Cell Protection as Plinabulin’s Mechanism of Action for CIN Accepted at American Society of Hematology’s 2019 Annual Meeting
PREV STORY
Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis erzielt im dritten Quartal starkes Wachstum und treibt Innovationen wie fortschrittlicheTherapieplattformen voran, um das zukünftige Wachstum zu beschleunigen

Der Nettoumsatz steigt um 6% (kWk[1], +3% USD), vor allem dank folgender Beiträge: Cosentyx erzielt ...

author_avatar
NASDAQ Market News

Allarity Therapeutics Publishes Interim Report for the Period January – September 2020

author_avatar
NASDAQ Market News

PDS Biotechnology Appoints Dr. Ilian Iliev to Board of Directors

author_avatar
NASDAQ Market News